Actualités

Apple (AAPL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Citi and Mizuho just cut their Microsoft price targets before fiscal Q4 earnings, yet both firms kept their bullish ratings intact. The reason behind that split signal could reshape how investors think about the AI spending wave ahead of July 29.

The PNC Financial Services Group (NYSE:PNC) reported what Chairman and CEO Bill Demchak called an “impressive” second quarter, with management pointing to broad-based business momentum, stronger fee income, continued commercial loan growth and stable credit quality. PNC generated second-quarter net

LUV's Q2 revenues are likely to benefit from resilient travel demand and improved pricing power, with rising labor costs acting as the key challenge.

Aehr Test Systems (NASDAQ:AEHR) shares jumped 30% after the semiconductor test and burn-in equipment provider reported fiscal fourth-quarter results that exceeded Wall Street expectations and provided a stronger-than-anticipated revenue outlook for fiscal 2027. The company posted adjusted...

Dell has emerged as an unexpected beneficiary after IBM's results highlighted a growing enterprise shift toward AI infrastructure investments.

PNC's Q2 2026 results gain from higher NII, fee income and loan growth. However, shares fall nearly 3.8% as expenses rise and deposits decline.

GE Vernova heads into Q2 results with AI-driven power demand, strong Power and Electrification growth, and persistent Wind pressures.

GE Aerospace (GE) could raise its 2026 adjusted EBIT guidance by about $500 million as strong servic

The big banks crushed earnings. Will other companies join in the party?

Shareholders of Boston Scientific would probably like to forget the past six months even happened. The stock dropped 52.5% and now trades at $42.79. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

Sandisk Corporation (NASDAQ:SNDK) is one of the Best Stocks to Buy Now for High Returns. The company is set to release its fiscal Q4 2026 earnings on August 5. The Street is bullish on the stock ahead of the earnings. Analysts’ 12-month average price target suggests more than 23% upside from the current level. ​Recently, […]

JNJ tops Q2 earnings and sales estimates, driven by key drug growth, and raises its 2026 outlook despite a slight MedTech sales miss.

Tesla may beat Q2 earnings estimates as deliveries and energy storage surge, but rich valuation, heavy AI spending and execution risks cloud the stock's appeal.

Johnson & Johnson (NYSE:JNJ) reported better-than-expected second quarter results and raised its full-year 2026 outlook, as strong pharmaceutical sales helped offset headwinds from products facing patent competition. The healthcare company posted adjusted earnings per share of $2.90 for...

TRV's Q2 results may benefit from pricing, premium growth and higher investment income, though storm losses can weigh on profitability.

AEHR beat fiscal Q4 estimates as AI and data-center demand drives 33.7% revenue growth, record bookings, and margin expansion.

ANGO's Q4 FY26 revenues rise 8% as Med Tech surges, while its adjusted loss beats estimates and FY27 sales guidance tops consensus.

Morgan Stanley's Q2 earnings surge 62.4% as record equity revenues, stronger IB and $10T in client assets fuel growth. MS raised its quarterly dividend 15%.

The streaming service reports critical financials on Thursday afternoon. Let's hope cameras are rolling.

Zebra Technologies is expected to announce its second-quarter earnings in August, and Wall Street forecasts a double-digit increase in its bottom line.

Morgan Stanley (NYSE:MS) reported record second-quarter 2026 results, with executives citing strong client activity across institutional securities, wealth management and investment management, as well as continued benefits from the firm’s integrated business model. Chairman and Chief Executive Off

Johnson & Johnson (NYSE:JNJ) raised its full-year 2026 outlook after reporting second-quarter sales growth that management said was supported by strength in Innovative Medicine, new product launches and a broad portfolio that helped offset continued pressure from STELARA biosimilar competition.

Tesla (TSLA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Alphabet (GOOGL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Liberty Energy (LBRT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Iridium (IRDM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Alphabet (GOOG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Texas Instruments (TXN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TE Connectivity (TEL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.